Predictive value of serum Hs-CRP levels for outcomes of pulmonary embolism

ARAZ Ö., YILMAZEL UÇAR E., Yalcin A., Kelercioglu N., MERAL M., Gorguner A. M., ...More

CLINICAL RESPIRATORY JOURNAL, vol.10, no.2, pp.163-167, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.1111/crj.12196
  • Journal Name: CLINICAL RESPIRATORY JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.163-167
  • Keywords: acute pulmonary embolism, fibrinolytic therapy, Hs-CRP, reperfusion duration, C-REACTIVE PROTEIN, VENOUS THROMBOEMBOLISM, EMERGENCY-DEPARTMENT, BIOMARKERS, MANAGEMENT, RISK
  • Marmara University Affiliated: Yes

Abstract

BackgroundThe diagnostic utility of novel biomarkers in patients with suspected pulmonary embolism (PE) is still under investigation. While many studies emphasize that high serum levels of high-sensitivity C-reactive protein (Hs-CRP) has a moderate relation with PE, few studies show that Hs-CRP can be used to predict the outcome of the treatment.